EcoDrugPlus

Tubulin, Beta 5

Ensembl ID : ENSPFOG00000015609
Gene Symbol: TUBB5
1 Cross references
215 Possible Orthologues:

Tubulin, Beta 6 Class V

Ensembl ID : ENSPFOG00000011581
Gene Symbol: TUBB6
1 Cross references
141 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSPFOG00000007470
Gene Symbol: TP53
2 Cross references
232 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPFOG00000007303
Gene Symbol: TYR
3 Cross references
202 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPFOG00000017399
Gene Symbol: TYR
2 Cross references
198 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSPFOG00000014072
Gene Symbol: TH
3 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSPFOG00000006605
Gene Symbol: TYK2
1 Cross references
195 Possible Orthologues:

Tyrosine-Protein Kinase Lyn-Like

Ensembl ID : ENSPFOG00000014008
Gene Symbol: LOC103151544
3 Cross references
195 Possible Orthologues:

Tyrosine-Protein Kinase Fyna-Like

Ensembl ID : ENSPFOG00000015722
Gene Symbol: LOC103155051
3 Cross references
191 Possible Orthologues:

Urotensin 2 Receptor

Ensembl ID : ENSPFOG00000018216
Gene Symbol: UTS2R
4 Cross references
97 Possible Orthologues:

Utrophin

Ensembl ID : ENSPFOG00000019599
Gene Symbol: UTRN
1 Cross references
270 Possible Orthologues:

Vascular Endothelial Growth Factor A

Ensembl ID : ENSPFOG00000023883
Gene Symbol: VEGFA
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).